| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Forschungszentrum Karlsruhe (J.V.M., S.B., U.H., A.M., A.C.B.C.), Institute of Toxicology and Genetics, D-76021 Karlsruhe, Germany; Molecular Biology of Tissue Specific Hormone Action (J.T.), Leibniz Institute for Age Research-Fritz-Lipmann-Institute e.V., D-07745 Jena, Germany; and Institute of Immunology (M.K., M.S.), Johannes Gutenberg University, Hochhaus am Augustusplatz, D-55131 Mainz, Germany
Address all correspondence and requests for reprints to: Andrew C. B. Cato, Forschungszentrum Karlsruhe, Institute of Toxicology and Genetics, P.O. Box 3640, D-76021 Karlsruhe, Germany. E-mail: andrew.cato{at}itg.fzk.de.
Dual specificity phosphatase DUSP1 (otherwise known as mitogen-activated phosphatase 1 or MKP-1) dephosphorylates MAPKs, particularly p38, and negatively regulates innate immunity. Recent studies have shown that the DUSP1 gene is transcriptionally up-regulated by glucocorticoids (GCs) and that the antiinflammatory action of GCs is impaired in DUSP1–/– mice. Here we show that GC-mediated dephosphorylation of ERK-1 and ERK-2 activated by IgE receptor cross-linking is unimpaired in bone marrow-derived mast cells (BMMCs) of DUSP1–/– mice. Dephosphorylation of phospho-p38 MAPK is impaired but only at early times of GC treatment. Proinflammatory cytokine and chemokine gene expression (CCL2, IL-6, TNF
) is still down-regulated by GCs in BMMCs from DUSP1–/– mice, suggesting a compensatory mechanism for the GC action in these mice. In both DUSP1+/+ and DUSP1–/– BMMCs, GC up-regulated the expression of several phosphatase genes (DUSP2, DUSP4, DUSP9, and PEST domain-enriched tyrosine phosphatase). DUSP1–/– mice show enhanced mast cell degranulation and are highly susceptible to anaphylaxis, but these effects are still down-regulated by GCs. GCs also repressed other inflammatory responses such as dinitrofluorobenzene-induced contact hypersensitivity and lipopolysaccharide-induced mortality in DUSP1–/– mice. Thus GC-mediated antiinflammatory action is largely independent of DUSP1.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
J. Carlson, W. Cui, Q. Zhang, X. Xu, F. Mercan, A. M. Bennett, and A. Vignery Role of MKP-1 in Osteoclasts and Bone Homeostasis Am. J. Pathol., October 1, 2009; 175(4): 1564 - 1573. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. M. Akinci, H. Turner, M. Taveras, A. Barash, Z. Wang, P. Reinach, and J. M. Wolosin Molecular Profiling of Conjunctival Epithelial Side-Population Stem Cells: Atypical Cell Surface Markers and Sources of a Slow-Cycling Phenotype Invest. Ophthalmol. Vis. Sci., September 1, 2009; 50(9): 4162 - 4172. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Kinney, U. M. Chandrasekharan, L. Yang, J. Shen, M. Kinter, M. S. McDermott, and P. E. DiCorleto Histone H3 as a novel substrate for MAP kinase phosphatase-1 Am J Physiol Cell Physiol, February 1, 2009; 296(2): C242 - C249. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. J. Cho and S. G. Kim A Novel Mitogen-Activated Protein Kinase Phosphatase-1 and Glucocorticoid Receptor (GR) Interacting Protein-1-Dependent Combinatorial Mechanism of Gene Transrepression by GR Mol. Endocrinol., January 1, 2009; 23(1): 86 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Johansson-Haque, E. Palanichamy, and S. Okret Stimulation of MAPK-phosphatase 1 gene expression by glucocorticoids occurs through a tethering mechanism involving C/EBP J. Mol. Endocrinol., October 1, 2008; 41(4): 239 - 249. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Clark, J. R. S. Martins, and C. R. Tchen Role of Dual Specificity Phosphatases in Biological Responses to Glucocorticoids J. Biol. Chem., September 19, 2008; 283(38): 25765 - 25769. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Diefenbacher, S. Sekula, C. Heilbock, J. V. Maier, M. Litfin, H. van Dam, M. Castellazzi, P. Herrlich, and O. Kassel Restriction to Fos Family Members of Trip6-Dependent Coactivation and Glucocorticoid Receptor-Dependent Trans-Repression of Activator Protein-1 Mol. Endocrinol., August 1, 2008; 22(8): 1767 - 1780. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |